Lung transplantation is just one in a spectrum of treatment options offered for patients with lung disease at the University of Maryland. For appropriate patients, we may be able to offer new medical treatments or experimental drug trials (research) as options. UMMC's transplant program is unique in the region in having the full spectrum of surgical and non-surgical options available to our patients.
This allows us to tailor our approach to each individual patient. In addition, we are committed to developing promising new approaches to the care of end-stage lung disease patients. In this way we are often able to offer patients who have no other good choices an opportunity to participate in clinical research trials that are not available elsewhere.
We continue to build a team of exceptionally well-trained, committed and gifted physicians, nurses, social workers, researchers and counselors whose special expertise guarantees that our patients receive the best treatment available. We are confident that as new advances are made -- and as we ourselves help to make them -- we will be able to help more people in the future.